LIMNW

Liminatus Pharma Warrants
LIMNW

Overview Fund Trends Analyst Outlook Journalist POV

25 hedge funds and large institutions have $837K invested in Liminatus Pharma Warrants in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$210K
2
+$193K
3
+$67.3K
4
LA
Linden Advisors
New York
+$56.3K
5
SCM
Saba Capital Management
New York
+$56.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$210K
CS
2
Clear Street
New York
$193K
AC
3
Aristeia Capital
Connecticut
$67.3K
LA
4
Linden Advisors
New York
$56.3K
SCM
5
Saba Capital Management
New York
$56.1K
HCM
6
Highbridge Capital Management
New York
$32.5K
MCM
7
Moore Capital Management
New York
$30.4K
MI
8
MMCAP International
Cayman Islands
$26.8K
PAMP
9
Polar Asset Management Partners
Ontario, Canada
$26.4K
WAM
10
Wolverine Asset Management
Illinois
$24.7K
AWG
11
Alpha Wave Global
New York
$21.6K
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$20.2K
PC
13
Periscope Capital
Ontario, Canada
$12K
BOCH
14
Blue Owl Capital Holdings
New York
$12K
Toronto Dominion Bank
15
Toronto Dominion Bank
Ontario, Canada
$8.44K
LP
16
LMR Partners
United Kingdom
$7.19K
ACA
17
Arena Capital Advisors
California
$7K
Jane Street
18
Jane Street
New York
$6.46K
LIA
19
Limestone Investment Advisors
New York
$5.41K
CSS
20
Cubist Systematic Strategies
Connecticut
$3.79K
MC
21
Meteora Capital
Florida
$3.6K
FTUS
22
Flow Traders U.S.
New York
$3K
DCM
23
Dupont Capital Management
Delaware
$1.52K
UBS Group
24
UBS Group
Switzerland
$485
HIM
25
HGC Investment Management
Ontario, Canada
$300
1
2